Stewart Sharon A, Dougall Greig M G, Tafuro Erica M
Clinical Research Department, GC Aesthetics, Cumbernauld, Scotland.
Plast Reconstr Surg Glob Open. 2016 Dec 23;4(12):e1183. doi: 10.1097/GOX.0000000000001183. eCollection 2016 Dec.
A single-center study assessing the efficacy of Nagor's Silgel STC-SE silicone gel to reduce the appearance of hypertrophic and keloid scars.
A 16-week controlled study of 36 patients with hypertrophic or keloid scars. The subjects were divided between 2 cohorts: one assessing recently healed scars (<6 mo) and other assessing older scars (6 mo to 2 y). The efficacy of Silgel STC-SE on the scar was evaluated by skin hydration, skin moisture evaporation, skin elasticity, basic scar measurements, subjective patient questionnaire data, and image analysis. All subjects had data collected at baseline and weeks 1, 4, 8, 12, and 16. Photographs were taken for image analysis at baseline, week 8, and week 16. Statistical analysis was conducted on all data.
Twenty-nine patients completed the study (27 presented with hypertrophic scars and 2 with keloid scars), and 90% reported a marked improvement in their scar appearance. Patient questionnaire data showed great satisfaction with the product. Image analysis showed visual improvement with a statistically significant reduction of the "red" color of scars. Overall, scar dimensions were significantly reduced. There was a significant decrease from baseline levels in average scar length. Skin elasticity, skin hydration, and skin moisture evaporation did not change significantly from baseline.
The results of this study indicate that Silgel STC-SE is an effective treatment in reducing the appearance and red color of hypertrophic scars up to 2 years old. Further study is required to draw significant conclusion in regard to the treatment of keloid scars.
一项单中心研究,评估Nagor的Silgel STC - SE硅胶凝胶减少增生性瘢痕和瘢痕疙瘩外观的疗效。
对36例增生性或瘢痕疙瘩性瘢痕患者进行为期16周的对照研究。受试者分为两个队列:一个评估近期愈合的瘢痕(<6个月),另一个评估较旧的瘢痕(6个月至2年)。通过皮肤水合作用、皮肤水分蒸发、皮肤弹性、基本瘢痕测量、患者主观问卷数据和图像分析来评估Silgel STC - SE对瘢痕的疗效。所有受试者在基线以及第1、4、8、12和16周收集数据。在基线、第8周和第16周拍摄照片用于图像分析。对所有数据进行统计分析。
29例患者完成了研究(27例为增生性瘢痕,2例为瘢痕疙瘩性瘢痕),90%的患者报告瘢痕外观有明显改善。患者问卷数据显示对该产品非常满意。图像分析显示有视觉改善,瘢痕的“红色”在统计学上显著减轻。总体而言,瘢痕尺寸显著减小。平均瘢痕长度较基线水平有显著下降。皮肤弹性、皮肤水合作用和皮肤水分蒸发与基线相比无显著变化。
本研究结果表明,Silgel STC - SE是一种有效治疗方法,可减少2岁以下增生性瘢痕的外观和红色。关于瘢痕疙瘩性瘢痕的治疗,需要进一步研究以得出有意义的结论。